Related references
Note: Only part of the references are listed.Pharmacogenomics of breast cancer: highlighting CYP2D6 and tamoxifen
Carmen W. H. Chan et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2020)
Epoxyeicosatrienoic intervention improves NAFLD in leptin receptor deficient mice by an increase in PGC1α-HO-1-PGC1α-mitochondrial signaling
Marco Raffaele et al.
EXPERIMENTAL CELL RESEARCH (2019)
Molecular Functionality of Cytochrome P450 4 (CYP4) Genetic Polymorphisms and Their Clinical Implications
Yazun Bashir Jarrar et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
The regulation of drug-metabolizing enzymes and membrane transporters by inflammation: Evidences in inflammatory diseases and age-related disorders
Kuo-Chen Wu et al.
JOURNAL OF FOOD AND DRUG ANALYSIS (2019)
Conflicting roles of 20-HETE in hypertension and renal end organ damage
Chao Zhang et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2018)
The relationship between the CYP2D6 polymorphisms and tamoxifen efficacy in adjuvant endocrine therapy of breast cancer patients in Chinese Han population
Bo Lan et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The Synthesis of Chalcones as Anticancer Prodrugs and their Bioactivation in CYP1 Expressing Breast Cancer Cells
Ketan C. Ruparelia et al.
MEDICINAL CHEMISTRY (2018)
Role of the cytochrome P-450/epoxyeicosatrienoic acids pathway in the pathogenesis of renal dysfunction in cirrhosis
Michael M. Yeboah et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2018)
Therapeutic targeting of noncoding RNAs in hepatocellular carcinoma: Recent progress and future prospects (Review)
Zhangang Xiao et al.
ONCOLOGY LETTERS (2018)
The Role of Cytochromes P450 in Infection
Elisavet Stavropoulou et al.
FRONTIERS IN IMMUNOLOGY (2018)
Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
Freddie Bray et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Influence of CYP2D6 polymorphism in the outcome of breast cancer patients undergoing tamoxifen adjuvant treatment.
Isabel Blancas et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Aptamers Against Pro- and Anti-Inflammatory Cytokines: A Review
Maryam Boshtam et al.
INFLAMMATION (2017)
Hyperhomocysteinemia results from and promotes hepatocellular carcinoma via CYP450 metabolism by CYP2J2 DNA methylation
Donghong Zhang et al.
ONCOTARGET (2017)
Discovery and characterization of novel CYP1B1 inhibitors based on heterocyclic chalcones: Overcoming cisplatin resistance in CYP1B1-overexpressing lines
Neill J. Horley et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2017)
Estrogen Metabolism-Associated CYP2D6 and IL6-174G/C Polymorphisms in Schistosoma haematobium Infection
Rita Cardoso et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2017)
PharmGKB summary: sorafenib pathways
Li Gong et al.
PHARMACOGENETICS AND GENOMICS (2017)
Role of the CYP3A4-mediated 11,12-epoxyeicosatrienoic acid pathway in the development of tamoxifen-resistant breast cancer
Nguyen Thi Thuy Phuong et al.
Oncotarget (2017)
Variation in CYP2A6 Activity and Personalized Medicine
Julie-Anne Tanner et al.
JOURNAL OF PERSONALIZED MEDICINE (2017)
CYP1A2 is a predictor of HCC recurrence in HCV-related chronic liver disease: A retrospective multicentric validation study
Amedeo Sciarra et al.
DIGESTIVE AND LIVER DISEASE (2017)
Genetic polymorphisms of phase I metabolizing enzyme genes, their interaction with lifetime grilled and smoked meat intake, and breast cancer incidence
Humberto Parada et al.
ANNALS OF EPIDEMIOLOGY (2017)
Drug-related genetic polymorphisms affecting severe chemotherapy-induced neutropenia in breast cancer patients A hospital-based observational study
Daiki Tsuji et al.
MEDICINE (2016)
Association between the CYP11 family and six cancer types
Ziwei Fan et al.
ONCOLOGY LETTERS (2016)
Changes in cytochrome P450s-mediated drug clearance in patients with hepatocellular carcinoma in vitro and in vivo: a bottom-up approach
Jie Gao et al.
ONCOTARGET (2016)
Significant change of cytochrome P450s activities in patients with hepatocellular carcinoma
Jun Zhou et al.
ONCOTARGET (2016)
Current Development of Anti-Cancer Drug S-1
Pratima Chhetri et al.
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH (2016)
Role of cytochrome P450 genes in breast cancer etiology and treatment: effects on estrogen biosynthesis, metabolism, and response to endocrine therapy
Heather L. Blackburn et al.
CANCER CAUSES & CONTROL (2015)
Effect of Natural Polyphenols on CYP Metabolism: Implications for Diseases
Ekaterina A. Korobkova
CHEMICAL RESEARCH IN TOXICOLOGY (2015)
Role of Metabolic Enzymes P450 (CYP) on Activating Procarcinogen and their Polymorphisms on the Risk of Cancers
Xin He et al.
CURRENT DRUG METABOLISM (2015)
Cytochrome P450 1 family and cancers
Ryeo-Eun Go et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2015)
Cisplatin-mediated cytotoxicity through inducing CYP4A 11 expression in human renal tubular epithelial cells
Jin Li et al.
JOURNAL OF TOXICOLOGICAL SCIENCES (2015)
Severely Impaired and Dysregulated Cytochrome P450 Expression and Activities in Hepatocellular Carcinoma: Implications for Personalized Treatment in Patients
Tongmeng Yan et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Developmental toxicity of hexachloronaphthalene in Wistar rats. A role of CYP1A1 expression
Anna Kilanowicz et al.
REPRODUCTIVE TOXICOLOGY (2015)
Association of the CYP24A1-rs2296241 polymorphism of the vitamin D catabolism enzyme with hormone-related cancer risk: a meta-analysis
Ping Wang et al.
ONCOTARGETS AND THERAPY (2015)
Modulation of Cytochrome P450 2A5 Activity by Lipopolysaccharide: Low-Dose Effects and Non-Monotonic Dose-Response Relationship
Ana C. A. X. De-Oliveira et al.
PLOS ONE (2015)
Impact of variable CYP genotypes on breast cancer relapse in patients undergoing adjuvant tamoxifen therapy
Jessica Mwinyi et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2014)
Pretreatment with turmeric modulates the inhibitory influence of cisplatin and paclitaxel on CYP2E1 and CYP3A1/2 in isolated rat hepatic microsomes
Enas M. Ahmed et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2014)
Analysis of the Human Tissue-specific Expression by Genome-wide Integration of Transcriptomics and Antibody-based Proteomics
Linn Fagerberg et al.
MOLECULAR & CELLULAR PROTEOMICS (2014)
The Cytochrome P450 Epoxygenase Pathway Regulates the Hepatic Inflammatory Response in Fatty Liver Disease
Robert N. Schuck et al.
PLOS ONE (2014)
Role of Constitutive Androstane Receptor in Toll-Like Receptor-Mediated Regulation of Gene Expression of Hepatic Drug-Metabolizing Enzymes and Transporters
Pranav Shah et al.
DRUG METABOLISM AND DISPOSITION (2014)
Polymorphism and single nucleotide polymorphisms (SNPs)
Greg Shaw
BJU INTERNATIONAL (2013)
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
Ulrich M. Zanger et al.
PHARMACOLOGY & THERAPEUTICS (2013)
Human cytochromes P450 in health and disease
Daniel W. Nebert et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY B-BIOLOGICAL SCIENCES (2013)
Effect of Lipopolysaccharide on the Xenobiotic-Induced Expression and Activity of Hepatic Cytochrome P450 in Mice
Nozomu Moriya et al.
BIOLOGICAL & PHARMACEUTICAL BULLETIN (2012)
Immunological response as a source to variability in drug metabolism and transport
Hege Christensen et al.
FRONTIERS IN PHARMACOLOGY (2012)
Cytochrome P450-Mediated Pulmonary Metabolism of Carcinogens Regulation and Cross-Talk in Lung Carcinogenesis
Sisko Anttila et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Tamoxifen, cytochrome P450 genes and breast cancer clinical outcomes
Madhu S. Singh et al.
BREAST (2011)
Phylogenetic-based propagation of functional annotations within the Gene Ontology consortium
Pascale Gaudet et al.
BRIEFINGS IN BIOINFORMATICS (2011)
Part 2: Pharmacogenetic Variability in Drug Transport and Phase I Anticancer Drug Metabolism
Maarten J. Deenen et al.
ONCOLOGIST (2011)
Increased Risk of Vincristine Neurotoxicity Associated With Low CYP3A5 Expression Genotype in Children With Acute Lymphoblastic Leukemia
Akinbode Egbelakin et al.
PEDIATRIC BLOOD & CANCER (2011)
Tegafur/gimeracil/oteracil (S-1) approved for the treatment of advanced gastric cancer in adults when given in combination with cisplatin: a review comparing it with other fluoropyrimidine-based therapies
Masao Kobayakawa et al.
ONCOTARGETS AND THERAPY (2011)
The influence of interferon-α on the pharmacokinetics of cyclophosphamide and its 4-hydroxy metabolite in patients with multiple myeloma
Moustapha Hassan et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2010)
Liver-specifi cytochrome P450 CYP2C22 is a direct target of retinoic acid and a retinoic acid-metabolizing enzyme in rat liver
Linxi Qian et al.
JOURNAL OF LIPID RESEARCH (2010)
CYP2D6 gene variants: association with breast cancer specific survival in a cohort of breast cancer patients from the United Kingdom treated with adjuvant tamoxifen
Jean E. Abraham et al.
BREAST CANCER RESEARCH (2010)
Comprehensive In Vitro Analysis of Voriconazole Inhibition of Eight Cytochrome P450 (CYP) Enzymes: Major Effect on CYPs 2B6, 2C9, 2C19, and 3A
Seongwook Jeong et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
GENETIC POLYMORPHISM OF METABOLIC ENZYMES P450 (CYP) AS A SUSCEPTIBILITY FACTOR FOR DRUG RESPONSE, TOXICITY, AND CANCER RISK
Nada Bozina et al.
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2009)
CYP2D6-CYP2C9 Protein-Protein Interactions and Isoform-Selective Effects on Substrate Binding and Catalysis
Murali Subramanian et al.
DRUG METABOLISM AND DISPOSITION (2009)
Regulation of CYP1A1 by heavy metals and consequences for drug metabolism
Anwar Anwar-Mohamed et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2009)
Acetaminophen bioactivation by human cytochrome P450 enzymes and animal microsomes
J. E. Laine et al.
XENOBIOTICA (2009)
Hepatic Cytochrome P450 Enzyme Alterations in Humans with Progressive Stages of Nonalcoholic Fatty Liver Disease
Craig D. Fisher et al.
DRUG METABOLISM AND DISPOSITION (2009)
The relative contribution of human cytochrome P450 isoforms to the four caffeine oxidation pathways:: An in vitro comparative study with cDNA-expressed P450s including CYP2C isoforms
Marta Kot et al.
BIOCHEMICAL PHARMACOLOGY (2008)
CYPIBI expression is induced by docetaxel: effect on cell viability and drug resistance
V. G. Martinez et al.
BRITISH JOURNAL OF CANCER (2008)
Expression of Cytochrome P450 in non-small cell lung cancer
">Tsunehiro Oyama
Frontiers in Bioscience-Landmark (2008)
Identification of the human cytochrome P450 enzymes involved in the in vitro biotransformation of lynestrenol and norethindrone
Tuomas Korhonen et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2008)
Gene-specific effects of inflammatory Cytokines on cytochrome P4502C, 2B6 and 3A4 mRNA levels in human Hepatocytes
Alison E. Aitken et al.
DRUG METABOLISM AND DISPOSITION (2007)
Assessment of ifosfamide pharmacokinetics, toxicity, and relation to CYP3A4 activity as measured by the erythromycin breath test in patients with sarcoma
Rashmi Chugh et al.
CANCER (2007)
Adaptations for the oxidation of polycyclic aromatic hydrocarbons exhibited by the structure of human P450 1A2
Stefaan Sansen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Cytochrome P450 expression (CYP) in non-small cell lung cancer
Tsunehiro Oyama et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2007)
Cytochrome P450 pharmacogenetics and cancer
C Rodriguez-Antona et al.
ONCOGENE (2006)
Cytochrome P450 enzymes in drug metabolism and chemical toxicology
LL Furge et al.
BIOCHEMISTRY AND MOLECULAR BIOLOGY EDUCATION (2006)
Cytochrome P450 and anticancer drugs
K Fujita
CURRENT DRUG METABOLISM (2006)
Structures of human microsomal cytochrome P450 2A6 complexed with coumarin and methoxsalen
JK Yano et al.
NATURE STRUCTURAL & MOLECULAR BIOLOGY (2005)
Genetic polymorphisms of cytochrome P450 in patients with hepatitis C virus-associated hepatocellular carcinoma
J Mochizuki et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2005)
Cytochrome P-450 1A1 gene polymorphisms and risk of breast cancer: A HuGE review
LF Masson et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Immunohistochemical evaluation of cytochrome P450 (CYP) and p53 in breast cancer
T Oyama et al.
FRONTIERS IN BIOSCIENCE (2005)
Interactions of mammalian cytochrome P450, NADPH-cytochrome P450 reductase, and cytochrome b5 enzymes
T Shimada et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2005)
CYP3A4 is a vitamin D-24- and 25-hydroxylase: Analysis of structure function by site-directed mutagenesis
RP Gupta et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2005)
Clinical pharmacokinetics of imatinib
B Peng et al.
CLINICAL PHARMACOKINETICS (2005)
Pharmacogenetics of cytochrome P450 and its applications in drug therapy: the past, present and future
M Ingelman-Sundberg
TRENDS IN PHARMACOLOGICAL SCIENCES (2004)
Characterization of human cytochrome P450 enzymes catalyzing domperidone N-dealkylation and hydroxylation in vitro
BA Ward et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2004)
Crystal structures of human cytochrome P450 3A4 bound to metyrapone and progesterone
PA Williams et al.
SCIENCE (2004)
Comparative, studies of the effects of two novel sugar drug candidates on the CYP 1A2 and CYP 2E1 enzymes in different sexed rats using a cocktail approach
M Shi et al.
MOLECULES (2004)
Cytochrome P450 gene polymorphism and cancer
JAG Agúndez
CURRENT DRUG METABOLISM (2004)
Hypercoagulable states in patients with hepatocellular carcinoma
DN Samonakis et al.
DIGESTIVE DISEASES AND SCIENCES (2004)
Expression of CYP2A3 mRNA and its regulation by 3-methylcholanthrene, pyrazole, and β-ionone in rat tissues
AB Robottom-Ferreira et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2003)
Clinical importance of the cytochromes P450
DW Nebert et al.
LANCET (2002)
Functional role of cytochrome P-450 2A3 in N-nitrosomethylbenzylamine metabolism in rat esophagus
R Gopalakrishnan et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2002)
Serum total homocysteine increases with the rapid proliferation rate of tumor cells and decline upon cell death: a potential new tumor marker
CF Sun et al.
CLINICA CHIMICA ACTA (2002)
Cytochrome P450CYP1B1 protein expression: a novel mechanism of anticancer drug resistance
MCE McFadyen et al.
BIOCHEMICAL PHARMACOLOGY (2001)
CYP 1A1 polymorphism and risk of lung cancer in relation to tobacco smoking: a case-control study in China
N Song et al.
CARCINOGENESIS (2001)
Share Paper
